201 related articles for article (PubMed ID: 19228071)
41. Effect of anionic PEGylated polypeptide on gene transfection mediated by glycolipid conjugate micelles.
Yi HX; Wu J; Du YZ; Hu YW; Yuan H; You J; Hu FQ
Mol Pharm; 2015 Apr; 12(4):1072-83. PubMed ID: 25490413
[TBL] [Abstract][Full Text] [Related]
42. Low molecular weight polyethylenimine cross-linked by 2-hydroxypropyl-gamma-cyclodextrin coupled to peptide targeting HER2 as a gene delivery vector.
Huang H; Yu H; Tang G; Wang Q; Li J
Biomaterials; 2010 Mar; 31(7):1830-8. PubMed ID: 19942284
[TBL] [Abstract][Full Text] [Related]
43. Decaarginine-PEG-liposome enhanced transfection efficiency and function of arginine length and PEG.
Furuhata M; Izumisawa T; Kawakami H; Toma K; Hattori Y; Maitani Y
Int J Pharm; 2009 Apr; 371(1-2):40-6. PubMed ID: 19135138
[TBL] [Abstract][Full Text] [Related]
44. Efficient topical delivery of plasmid DNA to lung in vivo mediated by putative triggered, PEGylated pDNA nanoparticles.
Aissaoui A; Chami M; Hussein M; Miller AD
J Control Release; 2011 Sep; 154(3):275-84. PubMed ID: 21699935
[TBL] [Abstract][Full Text] [Related]
45. Tumor-specific gene transfer with receptor-mediated nanocomplexes modified by polyethylene glycol shielding and endosomally cleavable lipid and peptide linkers.
Grosse SM; Tagalakis AD; Mustapa MF; Elbs M; Meng QH; Mohammadi A; Tabor AB; Hailes HC; Hart SL
FASEB J; 2010 Jul; 24(7):2301-13. PubMed ID: 20203088
[TBL] [Abstract][Full Text] [Related]
46. Encapsulation of plasmid DNA in stabilized plasmid-lipid particles composed of different cationic lipid concentration for optimal transfection activity.
Saravolac EG; Ludkovski O; Skirrow R; Ossanlou M; Zhang YP; Giesbrecht C; Thompson J; Thomas S; Stark H; Cullis PR; Scherrer P
J Drug Target; 2000; 7(6):423-37. PubMed ID: 10758913
[TBL] [Abstract][Full Text] [Related]
47. On the gene delivery efficacies of pH-sensitive cationic lipids via endosomal protonation: a chemical biology investigation.
Singh RS; Gonçalves C; Sandrin P; Pichon C; Midoux P; Chaudhuri A
Chem Biol; 2004 May; 11(5):713-23. PubMed ID: 15157882
[TBL] [Abstract][Full Text] [Related]
48. Cellular interactions and in vitro DNA transfection studies with poly(ethylene glycol)-modified gelatin nanoparticles.
Kaul G; Amiji M
J Pharm Sci; 2005 Jan; 94(1):184-98. PubMed ID: 15761942
[TBL] [Abstract][Full Text] [Related]
49. PEG-detachable polyplex micelles based on disulfide-linked block catiomers as bioresponsive nonviral gene vectors.
Takae S; Miyata K; Oba M; Ishii T; Nishiyama N; Itaka K; Yamasaki Y; Koyama H; Kataoka K
J Am Chem Soc; 2008 May; 130(18):6001-9. PubMed ID: 18396871
[TBL] [Abstract][Full Text] [Related]
50. Peptide T7-modified polypeptide with disulfide bonds for targeted delivery of plasmid DNA for gene therapy of prostate cancer.
Lu Y; Jiang W; Wu X; Huang S; Huang Z; Shi Y; Dai Q; Chen J; Ren F; Gao S
Int J Nanomedicine; 2018; 13():6913-6927. PubMed ID: 30464450
[TBL] [Abstract][Full Text] [Related]
51. "HFP" fluorinated cationic lipids for enhanced lipoplex stability and gene delivery.
Klein E; Ciobanu M; Klein J; Machi V; Leborgne C; Vandamme T; Frisch B; Pons F; Kichler A; Zuber G; Lebeau L
Bioconjug Chem; 2010 Feb; 21(2):360-71. PubMed ID: 20099841
[TBL] [Abstract][Full Text] [Related]
52. Stabilized plasmid-lipid particles: factors influencing plasmid entrapment and transfection properties.
Mok KW; Lam AM; Cullis PR
Biochim Biophys Acta; 1999 Jul; 1419(2):137-50. PubMed ID: 10407066
[TBL] [Abstract][Full Text] [Related]
53. A proline-rich peptide improves cell transfection of solid lipid nanoparticle-based non-viral vectors.
del Pozo-Rodríguez A; Pujals S; Delgado D; Solinís MA; Gascón AR; Giralt E; Pedraz JL
J Control Release; 2009 Jan; 133(1):52-9. PubMed ID: 18854203
[TBL] [Abstract][Full Text] [Related]
54. Role of liposome and peptide in the synergistic enhancement of transfection with a lipopolyplex vector.
Munye MM; Ravi J; Tagalakis AD; McCarthy D; Ryadnov MG; Hart SL
Sci Rep; 2015 Mar; 5():9292. PubMed ID: 25786833
[TBL] [Abstract][Full Text] [Related]
55. A new triantennary galactose-targeted PEGylated gene carrier, characterization of its complex with DNA, and transfection of hepatoma cells.
Frisch B; Carrière M; Largeau C; Mathey F; Masson C; Schuber F; Scherman D; Escriou V
Bioconjug Chem; 2004; 15(4):754-64. PubMed ID: 15264862
[TBL] [Abstract][Full Text] [Related]
56. Arginine-rich polyplexes for gene delivery to neuronal cells.
Morris VB; Labhasetwar V
Biomaterials; 2015 Aug; 60():151-60. PubMed ID: 26000961
[TBL] [Abstract][Full Text] [Related]
57. Reduction-triggered delivery using nucleoside-lipid based carriers possessing a cleavable PEG coating.
Oumzil K; Khiati S; Grinstaff MW; Barthélémy P
J Control Release; 2011 Apr; 151(2):123-30. PubMed ID: 21354443
[TBL] [Abstract][Full Text] [Related]
58. Transfection properties of stabilized plasmid-lipid particles containing cationic PEG lipids.
Palmer LR; Chen T; Lam AM; Fenske DB; Wong KF; MacLachlan I; Cullis PR
Biochim Biophys Acta; 2003 Apr; 1611(1-2):204-16. PubMed ID: 12659962
[TBL] [Abstract][Full Text] [Related]
59. Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alphavbeta3 and alphavbeta5 integrins.
Oba M; Fukushima S; Kanayama N; Aoyagi K; Nishiyama N; Koyama H; Kataoka K
Bioconjug Chem; 2007; 18(5):1415-23. PubMed ID: 17595054
[TBL] [Abstract][Full Text] [Related]
60. Divalent folate modification on PEG: an effective strategy for improving the cellular uptake and targetability of PEGylated polyamidoamine-polyethylenimine copolymer.
Cao D; Tian S; Huang H; Chen J; Pan S
Mol Pharm; 2015 Jan; 12(1):240-52. PubMed ID: 25514347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
